<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To investigate the expression status and clinical implications of stem cell genes CD133 and CD44 in the <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> with early <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: The differential genes of early <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were detected by RT(2) Profiler™ PCR Array </plain></SENT>
<SENT sid="2" pm="."><plain>The expression and the relationship of stem cell gene CD133 and CD44 were analyzed by immunofluorescent tests </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: CD133 and CD44 were significantly higher co-expressed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with early <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> compared to those without early <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>, and the content of CD133 and CD44 proteins decreased following growth of the transplanted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 80 cases without early <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>, 12 were observed CD133 and CD44 proteins co-expression, while 36 of the 40 cases with early <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> were found CD133 and CD44 proteins co-expression (15% vs. 90%, P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>Survival analysis revealed CD133 and CD44 proteins co-expression was associated with poorest prognosis (57.14% vs. 87.41%, X(2) = 48.49, P = 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>After Cox regression, age, Duck's stage, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and CD133 and CD44 proteins co-expression were shown to be the independent prognostic factors of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: CD133 and CD44 proteins were highly co-expressed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with early <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>, and may be a potential biomarker for the early <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
</text></document>